(Q42757786)

6 November 2017

The development of overt diabetes in young Zucker Diabetic Fatty (ZDF) rats and the effects of chronic MCC-555 treatment (English)

1 reference

6 November 2017

Pickavance L

1

1 reference

6 November 2017

Widdowson PS

2

1 reference

6 November 2017

King P

3

1 reference

6 November 2017

Ishii S

4

1 reference

6 November 2017

Tanaka H

5

1 reference

6 November 2017

Williams G

6

1 reference

6 November 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

British Journal of Pharmacology

6 November 2017

1 reference

6 November 2017

125

1 reference

6 November 2017

4

1 reference

6 November 2017

767-770

1 reference

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

6 November 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702158

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702158

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702158

7 January 2021

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702158

7 January 2021

Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702158

7 January 2021

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702158

7 January 2021

In Vivo Hepatic and Peripheral Insulin Resistance in Genetically Obese (fa/fa) Rats*

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702158

7 January 2021

Section Review: Oncologic, Endocrine & Metabolic: Thiazolidinediones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702158

7 January 2021

Management of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702158

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0702158

1 reference

6 November 2017

1 reference

6 November 2017

1 reference